Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action

Zasloff, 1987, Magainins, a class of antimicrobial peptides from Xenopus skin-isolation, characterization of two active forms, and partial cDNA sequence of a precursor, Proc. Natl. Acad. Sci. U. S. A., 84, 5449, 10.1073/pnas.84.15.5449

Steiner, 1981, Sequence and specificity of two anti-bacterial proteins involved in insect immunity, Nature, 292, 246, 10.1038/292246a0

Andersen, 2004, Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface, J. Med. Virol., 74, 262, 10.1002/jmv.20171

De Lucca, 1999, Antifungal peptides: novel therapeutic compounds against emerging pathogens, Antimicrob. Agents Chemother., 43, 1, 10.1128/AAC.43.1.1

Theis, 2004, Antifungal proteins: targets, mechanisms and prospective applications, Cell. Mol. Life Sci., 61, 437, 10.1007/s00018-003-3231-4

Papo, 2005, Host defense peptides as new weapons in cancer treatment, Cell. Mol. Life Sci., 62, 784, 10.1007/s00018-005-4560-2

Jerala, 2004, Endotoxin neutralizing peptides, Curr. Top. Med. Chem., 4, 1173, 10.2174/1568026043388079

McPhee, 2005, Design of host defence peptides for antimicrobial and immunity enhancing activities, Comb. Chem. High Throughput Screen., 8, 257, 10.2174/1386207053764558

Gifford, 2005, Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties, Cell. Mol. Life Sci., 62, 2588, 10.1007/s00018-005-5373-z

Yang, 1999, Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6, Science, 286, 525, 10.1126/science.286.5439.525

Hoover, 2002, The structure of human macrophage inflammatory protein-3 alpha/CCL20-Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins, J. Biol. Chem., 277, 37647, 10.1074/jbc.M203907200

Finken, 1993, Molecular-basis of streptomycin resistance in mycobacterium-tuberculosis—Alterations of the ribosomal-protein S12 gene and point mutations within a functional 16S ribosomal-RNA pseudoknot, Mol. Microbiol., 9, 1239, 10.1111/j.1365-2958.1993.tb01253.x

Spellberg, 2004, Trends in antimicrobial drug development: implications for the future, Clin. Infect. Dis., 38, 1279, 10.1086/420937

Brogden, 2005, Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?, Nat. Rev., Microbiol., 3, 238, 10.1038/nrmicro1098

Giacometti, 2005, In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi, J. Antimicrob. Chemother., 56, 410, 10.1093/jac/dki236

Giacometti, 2005, In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients, Int. J. Antimicrob. Agents, 26, 235, 10.1016/j.ijantimicag.2005.06.011

Pellegrini, 2003, Antimicrobial peptides from food proteins, Curr. Pharm. Des., 9, 1225, 10.2174/1381612033454865

Bradshaw, 2003, Cationic antimicrobial peptides: issues for potential clinical use, BioDrugs, 17, 233, 10.2165/00063030-200317040-00002

Ginsburg, 2004, Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics? It is enigmatic why this concept is consistently disregarded, Med. Hypotheses, 62, 367, 10.1016/j.mehy.2003.11.017

Miteva, 1999, Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin, FEBS Lett., 462, 155, 10.1016/S0014-5793(99)01520-3

Pokorny, 2004, Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides, Biochemistry, 43, 8846, 10.1021/bi0497087

Pokorny, 2005, Permeabilization of raft-containing lipid vesicles by delta-lysin: a mechanism for cell sensitivity to cytotoxic peptides, Biochemistry, 44, 9538, 10.1021/bi0506371

Hwang, 1998, Structure–function relationships of antimicrobial peptides, Biochem. Cell Biol., 76, 235, 10.1139/o98-026

Vogel, 2002, Towards a structure–function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides, Biochem. Cell Biol., 80, 49, 10.1139/o01-213

Strøm, 2002, Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity, Biochem. Cell Biol., 80, 65, 10.1139/o01-236

Yau, 1998, The preference of tryptophan for membrane interfaces, Biochemistry, 37, 14713, 10.1021/bi980809c

Persson, 1998, Molecular ordering of interfacially localized tryptophan analogs in ester- and ether-lipid bilayers studied by H-2-NMR, Biophys. J., 75, 1365, 10.1016/S0006-3495(98)74054-8

Killian, 1996, Induction of nonbilayer structures in diacylphosphatidylcholine model membranes by transmembrane alpha-helical peptides: Importance of hydrophobic mismatch and proposed role of tryptophans, Biochemistry, 35, 1037, 10.1021/bi9519258

Klein-Seetharaman, 2002, Long-range interactions within a nonnative protein, Science, 295, 1719, 10.1126/science.1067680

Blondelle, 1996, Use of nonsupport-bound synthetic combinatorial libraries in cell-based bioassay systems, Methods Mol. Cell. Biol., 6, 8

Mazze, 2005, A new amphipathy scale I. Determination of the scale from molecular dynamics data, Biochim. Biophys. Acta, 1747, 35

Dougherty, 1996, Cation–pi interactions in chemistry and biology: a new view of benzene Phe, Tyr, and Trp, Science, 271, 163, 10.1126/science.271.5246.163

Ma, 1997, The cation–pi interaction, Chem. Rev., 97, 1303, 10.1021/cr9603744

Flanagan, 2005, Double chromodomains cooperate to recognize the methylated histone H3 tail, Nature, 438, 1181, 10.1038/nature04290

Brehm, 2004, The many colours of chromodomains, BioEssays, 26, 133, 10.1002/bies.10392

Minoux, 1999, Cation–pi interactions in proteins: can simple models provide an accurate description?, J. Am. Chem. Soc., 121, 10366, 10.1021/ja990914p

Aliste, 2003, Molecular dynamics simulations of pentapeptides at interfaces: salt bridge and cation–pi interactions, Biochemistry, 42, 8976, 10.1021/bi027001j

Mitchell, 1994, Amino/aromatic interactions in proteins—Is the evidence stacked against hydrogen-bonding, J. Mol. Biol., 239, 315, 10.1006/jmbi.1994.1370

Jing, 2003, Conformation of a bactericidal domain of puroindoline a: structure and mechanism of action of a 13-residue antimicrobial peptide, J. Bacteriol., 185, 4938, 10.1128/JB.185.16.4938-4947.2003

Shepherd, 2003, Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations, Biochem. J., 370, 233, 10.1042/bj20021255

Petersen, 2005, Interfacial tryptophan residues: a role for the cation–pi effect?, Biophys. J., 89, 3985, 10.1529/biophysj.105.061804

Selsted, 1992, Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils, J. Biol. Chem., 267, 4292, 10.1016/S0021-9258(18)42830-X

Hsu, 2005, Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA, Nucleic Acids Res., 33, 4053, 10.1093/nar/gki725

Rozek, 2000, Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles, Biochemistry, 39, 15765, 10.1021/bi000714m

Wu, 1999, Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli, Biochemistry, 38, 7235, 10.1021/bi9826299

Subbalakshmi, 1998, Mechanism of antimicrobial action of indolicidin, FEMS Microbiol. Lett., 160, 91, 10.1111/j.1574-6968.1998.tb12896.x

Ryge, 2004, New indolicidin analogues with potent antibacterial activity, J. Pept. Res., 64, 171, 10.1111/j.1399-3011.2004.00177.x

Krajewski, 2004, Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin, Bioorg. Med. Chem. Lett., 14, 5595, 10.1016/j.bmcl.2004.08.061

Friedrich, 2001, Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria, J. Biol. Chem., 276, 24015, 10.1074/jbc.M009691200

Falla, 1997, Improved activity of a synthetic indolicidin analog, Antimicrob. Agents Chemother., 41, 771, 10.1128/AAC.41.4.771

Halevy, 2003, Membrane binding and permeation by indolicidin analogs studied by a biomimetic lipid/polydiacetylene vesicle assay, Peptides, 24, 1753, 10.1016/j.peptides.2003.08.019

Rozek, 2003, Structure-based design of an indolicidin peptide analogue with increased protease stability, Biochemistry, 42, 14130, 10.1021/bi035643g

Lawyer, 1996, Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides, FEBS Lett., 390, 95, 10.1016/0014-5793(96)00637-0

Schibli, 1999, Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold, Biochemistry, 38, 16749, 10.1021/bi990701c

Schibli, 2002, Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions, Biochem. Cell Biol., 80, 667, 10.1139/o02-147

Zasloff, 2002, Antimicrobial peptides of multicellular organisms, Nature, 415, 389, 10.1038/415389a

Matsuzaki, 1998, Relationship of membrane curvature to the formation of pores by magainin 2, Biochemistry, 37, 11856, 10.1021/bi980539y

Matsuzaki, 1999, Why and how are peptide–lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes, Biochim. Biophys. Acta, 1462, 1, 10.1016/S0005-2736(99)00197-2

Shai, 1999, Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides, Biochim. Biophys. Acta, 1462, 55, 10.1016/S0005-2736(99)00200-X

Yang, 2000, Crystallization of antimicrobial pores in membranes: magainin and protegrin, Biophys. J., 79, 2002, 10.1016/S0006-3495(00)76448-4

Salay, 2004, Ion channel-like activity of the antimicrobial peptide tritrpticin in planar lipid bilayers, FEBS Lett., 565, 171, 10.1016/j.febslet.2004.03.093

Blochet, 1993, Complete amino acid sequence of puroindoline, a new basic and cystine-rich protein with a unique tryptophan-rich domain, isolated from wheat endosperm by Triton X-114 phase partitioning, FEBS Lett., 329, 336, 10.1016/0014-5793(93)80249-T

Morris, 2002, Puroindolines: the molecular genetic basis of wheat grain hardness, Plant Mol. Biol., 48, 633, 10.1023/A:1014837431178

Krishnamurthy, 2001, Wheat puroindolines enhance fungal disease resistance in transgenic rice, Mol. Plant-Microb. Interact., 14, 1255, 10.1094/MPMI.2001.14.10.1255

Capparelli, 2005, Two plant puroindolines colocalize in wheat seed and in vitro synergistically fight against pathogens, Plant Mol. Biol., 58, 857, 10.1007/s11103-005-8270-9

Mattei, 1998, The wheat proteins puroindoline-a and alpha 1-purothionin induce nodal swelling in myelinated axons, NeuroReport, 9, 3803, 10.1097/00001756-199812010-00007

Le Guernevé, 1998, Interaction of the wheat endosperm lipid-binding protein puroindoline-a with phospholipids, Arch. Biochem. Biophys., 360, 179, 10.1006/abbi.1998.0931

Dubreil, 2003, Aggregation of puroindoline in phospholipid monolayers spread at the air–liquid interface, Biophys. J., 85, 2650, 10.1016/S0006-3495(03)74688-8

Hughes, 2000, The cytotoxic plant protein, beta-purothionin, forms ion channels in lipid membranes, J. Biol. Chem., 275, 823, 10.1074/jbc.275.2.823

Charnet, 2003, Puroindolines form ion channels in biological membranes, Biophys. J., 84, 2416, 10.1016/S0006-3495(03)75046-2

Blondelle, 1995, The antimicrobial activity of hexapeptides derived from synthetic combinatorial libraries, J. Appl. Bacteriol., 78, 39, 10.1111/j.1365-2672.1995.tb01671.x

Blondelle, 1996, Rapid identification of compounds with enhanced antimicrobial activity by using conformationally defined combinatorial libraries, Biochem. J., 313, 141, 10.1042/bj3130141

Blondelle, 1996, Novel antimicrobial compounds identified using synthetic combinatorial library technology, Trends Biotechnol., 14, 60, 10.1016/0167-7799(96)80922-X

Jing, 2003, The structure of the antimicrobial peptide Ac-RRWWRF-NH2 bound to micelles and its interactions with phospholipid bilayers, J. Pept. Res., 61, 219, 10.1034/j.1399-3011.2003.00050.x

Rezansoff, 2005, Interactions of the antimicrobial peptide Ac-FRWWHR-NH(2) with model membrane systems and bacterial cells, J. Pept. Res., 65, 491, 10.1111/j.1399-3011.2005.00263.x

Park, 2000, Structure–activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II, Proc. Natl. Acad. Sci. U. S. A., 97, 8245, 10.1073/pnas.150518097

Derossi, 1998, Trojan peptides: the penetratin system for intracellular delivery, Trends Cell Biol., 8, 84, 10.1016/S0962-8924(98)80017-2

Wessolowski, 2004, Antimicrobial activity of arginine- and tryptophan-rich hexapeptides: the effects of aromatic clusters, D-amino acid substitution and cyclization, J. Pept. Res., 64, 159, 10.1111/j.1399-3011.2004.00182.x

Dathe, 2004, Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides, Biochemistry, 43, 9140, 10.1021/bi035948v

Appelt, 2005, Structure of the antimicrobial, cationic hexapeptide cyclo(RRWWRF) and its analogues in solution and bound to detergent micelles, ChemBioChem, 6, 1654, 10.1002/cbic.200500095

Appelt, 2005, Interaction of the antimicrobial peptide cyclo(RRWWRF) with membranes by molecular dynamics simulations, Biophys. J., 89, 2296, 10.1529/biophysj.105.063040

Levay, 1995, Lactoferrin: a general review, Haematologica, 80, 252

Singh, 2002, A component of innate immunity prevents bacterial biofilm development, Nature, 417, 552, 10.1038/417552a

Tomita, 1991, Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin, J. Dairy Sci., 74, 4137, 10.3168/jds.S0022-0302(91)78608-6

van der Kraan, 2004, Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin, Peptides, 25, 177, 10.1016/j.peptides.2003.12.006

Pellegrini, 1997, Identification and isolation of a bactericidal domain in chicken egg white lysozyme, J. Appl. Microbiol., 82, 372, 10.1046/j.1365-2672.1997.00372.x

Bellamy, 1992, Identification of the bactericidal domain of lactoferrin, Biochim. Biophys. Acta, 1121, 130, 10.1016/0167-4838(92)90346-F

Yamauchi, 1993, Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment, Infect. Immun., 61, 719, 10.1128/IAI.61.2.719-728.1993

Bellamy, 1992, Antibacterial spectrum of lactoferricin-B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin, J. Appl. Bacteriol., 73, 472, 10.1111/j.1365-2672.1992.tb05007.x

Bellamy, 1994, Antifungal properties of lactoferricin-B, a peptide derived from the N-terminal region of bovine lactoferrin, Lett. Appl. Microbiol., 18, 230, 10.1111/j.1472-765X.1994.tb00854.x

Rekdal, 1999, Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity, J. Pept. Sci., 5, 32, 10.1002/(SICI)1099-1387(199901)5:1<32::AID-PSC172>3.0.CO;2-9

Kang, 1996, Structure–biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin, Int. J. Pept. Protein Res., 48, 357, 10.1111/j.1399-3011.1996.tb00852.x

Tomita, 1994, A review: the active peptide of lactoferrin, Acta Paediatr. Jpn., 36, 585, 10.1111/j.1442-200X.1994.tb03250.x

Hwang, 1998, Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin, Biochemistry, 37, 4288, 10.1021/bi972323m

Moore, 1997, Three-dimensional structure of diferric bovine lactoferrin at 2.8 angstrom resolution, J. Mol. Biol., 274, 222, 10.1006/jmbi.1997.1386

Zhou, 2004, Molecular dynamics simulations of bovine lactoferricin: turning a helix into a sheet, Biometals, 17, 217, 10.1023/B:BIOM.0000027695.99874.ea

Schibli, 1999, The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles, FEBS Lett., 446, 213, 10.1016/S0014-5793(99)00214-8

Nguyen, 2005, Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin, J. Pept. Sci., 11, 379, 10.1002/psc.629

Strøm, 2000, Antibacterial activity of 15-residue lactoferricin derivatives, J. Pept. Res., 56, 265, 10.1034/j.1399-3011.2000.00770.x

Haug, 2001, Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives, J. Pept. Sci., 7, 425, 10.1002/psc.338

Haug, 2001, The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide, J. Pept. Sci., 7, 190, 10.1002/psc.318

Hunter, 2005, Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent, Antimicrob. Agents Chemother, 49, 3387, 10.1128/AAC.49.8.3387-3395.2005

Schwaiger, 1998, NMR investigation of the multidrug transporter EmrE, an integral membrane protein, Eur. J. Biochem., 254, 610, 10.1046/j.1432-1327.1998.2540610.x

Girvin, 1998, Solution structure of the transmembrane H+-transporting subunit c of the F1F0 ATP synthase, Biochemistry, 37, 8817, 10.1021/bi980511m

Sun, 1999, Structure of recombinant human lactoferrin expressed in Aspergillus awamori, Acta Crystallogr., D Biol. Crystallogr., 55, 403, 10.1107/S0907444998011226

Chapple, 2004, Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide, Antimicrob. Agents Chemother., 48, 2190, 10.1128/AAC.48.6.2190-2198.2004

Shin, 1998, Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157 : H7, Lett. Appl. Microbiol., 26, 407, 10.1046/j.1472-765X.1998.00358.x

Haukland, 2001, The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm, FEBS Lett., 508, 389, 10.1016/S0014-5793(01)03100-3

He, 1995, Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA, Nature, 373, 721, 10.1038/373721a0

Joliot, 2004, Transduction peptides: from technology to physiology, Nat. Cell Biol., 6, 189, 10.1038/ncb0304-189

Lensink, 2005, Penetratin–membrane association: W48/R52/W56 shield the peptide from the aqueous phase, Biophys.J., 88, 939, 10.1529/biophysj.104.052787

Ulvatne, 2004, Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis, FEMS Microbiol. Lett., 237, 377

Jolles, 1984, What's new in lysozyme research—Always a model system, today as yesterday, Mol. Cell. Biochem., 63, 165

Pellegrini, 1992, Bactericidal activities of lysozyme and aprotinin against Gram-negative and Gram-positive bacteria related to their basic character, J. Appl. Bacteriol., 72, 180, 10.1111/j.1365-2672.1992.tb01821.x

Ibrahim, 2005, Processing of lysozyme at distinct loops by pepsin: a novel action for generating multiple antimicrobial peptide motifs in the newborn stomach, Biochim. Biophys. Acta, 1726, 102, 10.1016/j.bbagen.2005.07.008

Mine, 2004, Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme, J. Agric. Food Chem., 52, 1088, 10.1021/jf0345752

Düring, 1999, The non-enzymatic microbicidal activity of lysozymes, FEBS Lett., 449, 93, 10.1016/S0014-5793(99)00405-6

Ibrahim, 2001, A helix–loop–helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action, J. Biol. Chem., 276, 43767, 10.1074/jbc.M106317200

Hunter, 2005, The interactions of antimicrobial peptides derived from lysozyme with model membrane systems, Biochim. Biophys. Acta, 1668, 175, 10.1016/j.bbamem.2004.12.004

Park, 1998, Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions, Biochem. Biophys. Res. Commun., 244, 253, 10.1006/bbrc.1998.8159

Pellegrini, 2000, Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli, Microbiol. Res., 155, 69, 10.1016/S0944-5013(00)80040-3

Wei, 2006, Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity, J. Bacteriol., 188, 328, 10.1128/JB.188.1.328-334.2006

Deslouches, 2005, Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications, Antimicrob. Agents Chemother., 49, 3208, 10.1128/AAC.49.8.3208-3216.2005

Deslouches, 2005, De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity, Antimicrob. Agents Chemother., 49, 316, 10.1128/AAC.49.1.316-322.2005

Yoo, 1997, Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species, Biochem. Biophys. Res. Commun., 237, 624, 10.1006/bbrc.1997.7199

Yoo, 1997, Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice, Jpn. J. Cancer Res., 88, 184, 10.1111/j.1349-7006.1997.tb00364.x

Eliassen, 2002, Evidence for a direct antitumor mechanism of action of bovine lactoferricin, Anticancer Res., 22, 2703

Yang, 2002, Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide, Biochem. Biophys. Res. Commun., 296, 1044, 10.1016/S0006-291X(02)02048-X

Falla, 1996, Mode of action of the antimicrobial peptide indolicidin, J. Biol. Chem., 271, 19298, 10.1074/jbc.271.32.19298

Vorland, 1998, Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin, Scand. J. Infect. Dis., 30, 513, 10.1080/00365549850161557

Wakabayashi, 2003, Lactoferricin derived from milk protein lactoferrin, Curr. Pharm. Des, 9, 1277, 10.2174/1381612033454829

Chapple, 1998, Structure–function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111, Infect. Immun., 66, 2434, 10.1128/IAI.66.6.2434-2440.1998

Lupetti, 2000, Candidacidal activities of human lactoferrin peptides derived from the N terminus, Antimicrob. Agents Chemother., 44, 3257, 10.1128/AAC.44.12.3257-3263.2000

Tieleman, 2004, The molecular basis of electroporation, BMC Biochem., 5, 10, 10.1186/1471-2091-5-10